- R/R MCL approval and launch with priority review
Interspersed is potential upside news on myeloma, maybe pancreatic, autoimmune compound, firm European filing plans, filing plans for Japan and Asia, regulatory and approval milestones, trial enrollment news, next two breakthrough designation approvals, then first line approvals.
May 9 is the annual meeting. My guess is that they'll hold off the Q1 discussion until the ASCO conference call. Like last year.
Someone posted that it was announced as an SEC filing
Item 8.01. Other Events.
Pharmacyclics, Inc. (the "Company") will hold its 2013 Annual Meeting of Stockholders on Thursday, May 9, 2013 at 1:00 p.m. local time at the Company's headquarters, 999 E. Arques Avenue, Sunnyvale, California 94085.